Mechanisms of renal phosphate loss in liver resection-associated hypophosphatemia

Annals of Surgery

Volumn 249, Issue 5, 2009, Pages 824-827

  Nafidi, Otmane ^a   Lapointe, Real W ^a   Lepage, Raymond ^a   Kumar, Rajiv ^b   D'Amour, Pierre ^a  

^a UNIVERSITY OF MONTREAL   (Canada)

^b MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM; FIBROBLAST GROWTH FACTOR 23; KERATINOCYTE GROWTH FACTOR; PARATHYROID HORMONE; PHOSPHATE; PHOSPHATONIN; SECRETED FRIZZLED RELATED PROTEIN 4; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CALCIUM BLOOD LEVEL; CLINICAL ARTICLE; FEMALE; HUMAN; HYPOPHOSPHATEMIA; KIDNEY METABOLISM; LIVER RESECTION; LIVER SURGERY; MALE; PATHOPHYSIOLOGY; PH MEASUREMENT; PHOSPHATE BALANCE; PHOSPHATE BLOOD LEVEL; PRIORITY JOURNAL; RENAL PHOSPHATE LOSS; URINARY EXCRETION;

ADULT; AGED; FEMALE; FIBROBLAST GROWTH FACTOR 7; FIBROBLAST GROWTH FACTORS; HEPATECTOMY; HUMANS; HYPOPHOSPHATEMIA; KIDNEY; KIDNEY DISEASES; MALE; MIDDLE AGED; PARATHYROID HORMONE; PHOSPHATES; PROTO-ONCOGENE PROTEINS;

EID: 67649547471     PISSN: 00034932     EISSN: 15281140     Source Type: Journal    
DOI: 10.1097/SLA.0b013e3181a3e562     Document Type: Article

References (30)

1. Nafidi O, Lepage R, Lapointe RW, et al. Hepatic resection-related hypophosphatemia is of renal origin as manifested by isolated hyperphosphaturia. Ann Surg. 2007;245:1000-1002.
2. Salem RR, Tray K. Hepatic resection-related hypophosphatemia is of renal origin as manifested by isolated hyperphosphaturia. Ann Surg. 2005;241:343-348.
3. Giovannini I, Chiarla C, Giuliante F, et al. Hepatic resection-related hypophosphatemia is of renal origin as manifested by isolated hyperphosphaturia. Ann Surg. 2006;243:429.
4. Cohen J, Kogan A, Sahar G, et al. Hypophosphatemia following open heart surgery: incidence and consequences. Eur J Cardiothorac Surg. 2004;26: 306-310.
5. Datta HK, Malik M, Neely RD. Hepatic surgery-related hypophosphatemia. Clin Chim Acta. 2007;380:13-23.
6. Hettleman BD, Sabina RL, Drezner MK, et al. Defective adenosine triphosphate synthesis. An explanation for skeletal muscle dysfunction in phosphate-deficient mice. J Clin Invest. 1983;72:582-589.
7. Preston CJ, Noorwali A, Challa A, et al. Intracellular inorganic phosphate and ATP levels in human blood erythrocytes, leucocytes and platelets in normal subjects and in diseases associated with altered phosphate metabolism. Adv Exp Med Biol. 1982;151:147-155.
8. Young JA, Lichtman MA, Cohen J. Reduced red cell 2,3-diphosphoglycerate and adenosine triphosphate, hypophosphatemia, and increased hemoglobin-oxygen affinity after cardiac surgery. Circulation. 1973;47:1313-1318.
9. Ambuhl PM, Meier D, Wolf B, et al. Metabolic aspects of phosphate replacement therapy for hypophosphatemia after renal transplantation: impact on muscular phosphate content, mineral metabolism, and acid/base homeostasis. Am J Kidney Dis. 1999;34:875-883.
10. Amanzadeh J, Reilly RF Jr. Hypophosphatemia: an evidence-based approach to its clinical consequences and management [review]. Nat Clin Pract Nephrol. 2006;2:136-148.
11. Miller DW, Slovis CM. Hypophosphatemia in the emergency department therapeutics. Am J Emerg Med. 2000;18:457-461.
12. Dondero F, Taille C, Mal H, et al. Respiratory complications: a major concern after right hepatectomy in living liver donors. Transplantation. 2006;81:181-186.
13. Burak KW, Rosen CB, Fidler JL, et al. Hypophosphataemia after right hepatectomy for living donor liver transplantation. Can J Gastroenterol. 2004;18:729-733.
14. Shaikh A, Berndt T, Kumar R. Regulation of phosphate homeostasis by the phosphatonins and other novel mediators. Pediatr Nephrol. 2008;23:1203-1210.
15. Lepage R, Legare G, Racicot C, et al. Hypocalcemia induced during major and minor abdominal surgery in humans. J Clin Endocrinol Metab. 1999;84: 2654-2658.
16. Schiavi SC, Kumar R. The phosphatonin pathway: new insights in phosphate homeostasis [review]. Kidney Int. 2004;65:1-14.
17. Berndt T, Kumar R. Phosphatonins and the regulation of phosphate homeostasis [review]. Annu Rev Physiol. 2007;69:341-359.
18. Berndt T, Craig TA, Bowe AE, et al. Secreted frizzled-related protein 4 is a potent tumor-derived phosphaturic agent. J Clin Invest. 2003;112:785-794.
19. Palmese S, Pezza M, De Robertis E. Hypophosphatemia and metabolic acidosis. Minerva Anestesiol. 2005;71:237-242.
20. Lotscher M, Scarpetta Y, Levi M, et al. Rapid downregulation of rat renal Na/P(i) cotransporter in response to parathyroid hormone involves microtubule rearrangement. J Clin Invest. 1999;104:483-494.
21. Friedlaender MM, Wald H, Dranitzky-Elhalel M, et al. Recovery of renal tubule phosphate reabsorption despite reduced levels of sodium-phosphate transporter. Eur J Endocrinol. 2004;151:797-801.
22. Sommer S, Berndt T, Craig T, et al. The phosphatonins and the regulation of phosphate transport and vitamin D metabolism. J Steroid Biochem Mol Biol. 2007;103:497-503.
23. Perwad F, Zhang MY, Tenenhouse HS, et al. Fibroblast growth factor 23 impairs phosphorus and vitamin D metabolism in vivo and suppresses 25-hydroxyvitamin D-1alpha-hydroxylase expression in vitro. Am J Physiol Renal Physiol. 2007;293:F1577-F1583.
24. Frishberg Y, Topaz O, Bergman R, et al. Identification of a recurrent mutation in GALNT3 demonstrates that hyperostosis-hyperphosphatemia syndrome and familial tumoral calcinosis are allelic disorders. J Mol Med. 2005;83:33-38.
25. Tebben P, Kalli KR, Cliby WA, et al. Elevated fibroblast growth factor 23 concentrations in women with malignant ovarian tumors. Mayo Clin Proc. 2005;80:745-751.
26. Carpenter TO, Ellis BK, Insogna KL, et al. Fibroblast growth factor 7: an inhibitor of phosphate transport derived from oncogenic osteomalacia-causing tumors. J Clin Endocrinol Metab. 2004;90:1012-1020.
27. Danilenko DM. Preclinical and early clinical development of keratinocyte growth factor, an epithelial-specific tissue growth factor. Toxicol Pathol. 1999;27:64-71.
28. Cancilla B, Davies A, Cauchi JA, et al. Fibroblast growth factor receptors and their ligands in the adult rat kidney. Kidney Int. 2001;60:147-155.
29. Berndt TJ, Bielesz B, Craig TA, et al. Secreted frizzled-related protein-4 reduces sodium-phosphate co-transporter abundance and activity in proximal tubule cells. Pflugers Arch. 2006;451:579-587.
30. Guicciardi ME, Deussing J, Miyoshi H, et al. Cathepsin B contributes to TNF-alpha-mediated hepatocyte apoptosis by promoting mitochondrial release of cytochrome c. J Clin Invest. 2000;106:1127-1137.